Anders Strid is Head of Vinge's Capital Markets group in Gothenburg and specializes in Corporate Governance, private and public M&A and company law. He is efficient, pragmatic and solution-oriented and has extensive experience in IPO, issues of shares and debt instruments as well as advice to listed companies, their owners and subsidiaries on all kinds of issues related to capital markets and company law, including incentive programmes. Anders has special knowledge and experience in Healthcare, Life Science, Biotech, IT, Automotive and Industry.
Anders Strid is ranked as Notable practitioner and is described by clients as “Efficient.” - IFLR 1000 2019
Vinge has advised the sellers in connection with the sale of all shares in Mark Bric AB to Sareq AB.…
Vinge advises Irisity AB (publ) in connection with its rights issue of units consisting of shares an…
Vinge had advised Bilia AB (publ) in connection with the SEK 2.3 billion refinancing of its existing…
Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish…
Vinge advises Irisity AB in connection with the acquisition of Ultinous and a directed share issue
Vinge has advised Byggfakta Group Nordic HoldCo AB (publ) in connection with a public takeover offer…
Vinge has advised Sileon AB (publ) in connection with its rights issue, which provides the company w…
Vinge has advised XVIVO Perfusion AB in connection with its directed share issue at a subscription p…
Vinge has advised Bilia AB in connection with its issuance of senior unsecured floating rate bonds i…
Vinge has advised Trantema Group AB (Nasdaq Stockholm) in connection with a directed share issue of…
Vinge has advised Smart Eye Aktiebolag (First North Growth Market) in connection with its fully secu…
Vinge has advised Byggfakta Group (Nasdaq Stockholm) in conjunction with the acquisition of approxim…
Vinge has advised BICO Group AB in connection with a directed share issue to Sartorius AG, adding a…
Vinge is advising Semcon AB (publ) due to the fact that Ratos AB has provided a competing recommende…
Vinge has advised Semcon AB (publ) in connection with a public takeover offer provided by Etteplan O…
Vinge has advised Paynova AB, under change of name to Sileon AB, in connection with a fully subscrib…
Vinge has advised Promimic AB (publ) in connection with its listing on Nasdaq First North Growth Mar…
Vinge is advising Capio in connection with its acquisition of all shares in PR Vård Hemsjukvåd AB an…
Vinge has advised Norditek Group AB in connection with its listing on Nasdaq First North Growth Mark…
Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the c…
Vinge has advised XVIVO Perfusion AB in connection with a directed new issue of shares to Swedish an…
Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish…
Vinge has advised Isofol Medical AB in connection with its listing on Nasdaq Stockholm, with the fir…
The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK…
Vinge has advised BICO Group AB in connection with a directed issue of new shares for approximately…
Vinge has advised Transtema in connection with its application for admission to trading on Nasdaq St…
Vinge has advised Irisity AB (publ) in connection with its acquisition of all shares in the Israeli…
Vinge has advised TransPerfect Global Inc., the world’s leading provider of language and technology…
Surgical Science Sweden AB, listed on Nasdaq First North Growth Market, has performed a directed new…
Vinge has advised Isofol Medical AB (publ), Nasdaq First North Premier Growth Market, in connection…
Vinge has advised Smart Eye Aktiebolag (publ) in connection with a directed new share issue of MSEK…
Vinge has advised the owners of Moldeo AB in connection with the sale of all shares to Iwmac Holding…
Vinge has advised CELLINK AB (publ) in connection with a directed issue of covertibles of SEK 1.5 bi…
Vinge has advised CELLINK AB (publ) in connection with the acquisition of all shares in Ginolis Oy.…
Vinge has advised Smart Eye AB in connection with a directed new issue of 1 511 898 new shares at a…
Vinge has advised Bilia in connection with an offer for the repurchase of previously issued bonds as…
Vinge has advised Cellink AB, listed on Nasdaq Stockholm, in connection with the acquisition of all…
Vinge has advised Cellink in connection with directed new issues of shares of approximately 5.9 mill…
Vinge has advised CELLINK AB (publ) in connection with its list change from Nasdaq First North Growt…
Vinge has advised Isofol Medical AB (publ), First North Growth Market Premier, in connection with it…
Vinge has advised CELLINK AB (publ) in connection with a directed issue of new shares which will gen…
Ograi BidCo AB has announced a public offer to the shareholders of Opus Group AB (publ) to tender al…
Vinge is advising Irisity in connection with a directed new share issue of 4,094,000 shares whereby…
Vinge has advised in connection with the sale of all of the shares in Väggmaterial i Sverige AB to V…
Vinge has advised Cellink AB (publ) in connection with the acquisition of all shares in cytena GmbH.…
Vinge has advised Smart Eye AB (Nasdaq First North) on a directed new share issue that provides Smar…
The board of directors of Jays Group AB (publ) has resolved pursuant to authorization granted at an…
Vinge has advised the sellers in connection with the sale of all shares in Bygglet Holding AB to Cor…
Vinge has advised CELLINK AB, listed on First North Stockholm, in connection with the acquisition of…
Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of…
Vinge has advised Hexatronic Group AB (publ), listed on Nasdaq Stockholm mid‑cap, in connection with…
Vinge has advised Bilia AB (publ) in connection with the issue of new senior and non subordinated bo…
Vinge has advised Transtema in connection with a rights issue.
Vinge has advised Smart Eye AB (publ) in connection with a directed issue of new shares to instituti…
Transtema Group AB (publ), listed on Nasdaq First North, has entered into an agreement to acquire Er…
Vinge advised American Melody Capital Partners with affiliates in connection to a share issue of a v…
Vinge has advised Cellink AB (publ) in connection with a directed new issue of shares to Swedish and…
Opus Group AB (publ) (”Opus”) has issued a so called senior unsecured bond in the amount of MSEK 500…
Vinge has advised Jays Group AB (publ), listed on Nasdaq First North, in connection with the acquisi…
Vinge has advised Capio, which is listed on Nasdaq Stockholm, in connection with the acquisition of…
Jays will acquire approximately MSEK 25 in connection with a rights issue and in conjunction with th…
Vinge, together with Ellis & Winter LLP, has advised Hexatronic Group AB (publ) in connection wi…
Vinge is advising Irisity AB (publ), listed on Nasdaq First North, in connection with a rights issue…
Vinge has advised the seller in connection with the sale of all shares in Hans Recycling Group AB to…
Vinge has advised Isofol Medical AB (publ) in connection with its listing on Nasdaq First North Prem…
Vinge has advised Bilia AB (publ), listed on NASDAQ Stockholm, in conjunction with a tap issue of MS…
Vinge has advised Conceptor Handel AS in connection with the sale of the entire issued share capital…
Capio Närsjukvård AB, a wholly owned subsidiary of Capio AB (publ) listed on Nasdaq Stockholm, has e…
Vinge has advised Hexatronic Group AB (publ), listed on Nasdaq Stockholm, in conjunction with the ac…
Vinge has advised Smart Eye AB in connection with the listing of Smart Eye’s shares on Nasdaq First…
Vinge has advised Hexatronic Group AB (publ), listed on Nasdaq Stockholm, in connection with the acq…
Vinge has advised CELLINK AB (publ) in connection with its listing on Nasdaq First North.
Capio Specialistkliniker AB has entered into an agreement to acquire all shares in Scanloc Healthcar…
Vinge has advised Hexatronic Group AB, listed on Nasdaq Stockholm, in connection with the acquisitio…
The economic challenges following from the outbreak of Covid-19 have, and will continue to have, a s…
